ARTICLE | Clinical News
Endostatin: Began Phase I testing
October 4, 1999 7:00 AM UTC
EntreMed Inc. (ENMD), Rockville, Md. Product: Endostatin Business: Cancer Therapeutic category: Angiogenesis Target: Tumor blood vessels Description: Recombinant human endostatin protein fragment of ...